P-203 - ISLATRAVIR INTRACELLULAR TRIPHOSPHATE T1/2 SUPPORTS EXTENDED DOSE INTERVALS.

W. Ankrom¹, X. Zang¹, J. Spiridigliozzi¹, W. Kraft², R. Vargo¹, A. Stoch¹, M. Iwamoto¹, R. Matthews¹; ¹Merck & Co., Inc., Kenilworth, NJ, USA, ²Thomas Jefferson University, Philadelphia, PA, USA.

Presenting Author(s)

Xiaowei Zang, BS, MS, PhD

Associate Principal Scientist
Merck & Co., Inc., Pennsylvania, United States